Skip to main content
    N

    Novartis AG ADR (NVS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $159.16
    -1.04 (-0.65%)

    Market Cap: $303.12B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Novartis AG ADR (NVS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Novartis AG ADR (NVS) has a market cap of $303.12B and an enterprise value of $340.60B. Its trailing P/E is 18.6x.

    Total Valuation

    Enterprise value is 12.36% above the market cap, as debt exceeds cash.

    Market Cap$303.12B
    Enterprise Value$340.60B
    Latest price (Nov 17, 2026)$159.16

    Key Dates

    The last ex-dividend date was Mar 11, 2026.

    Last Earnings DateOct 27, 2026
    Last Ex-Dividend DateMar 11, 2026
    Last Payment DateMar 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.47% in the quarter ended Sep 30, 2026 and shrank 3.06% a year over 2 years.

    Shares Outstanding1.91B
    Shares Change (YoY)-1.80%
    Shares Change (QoQ)-0.47%
    Share Count Growth (2Y CAGR)-3.06%

    Valuation Ratios

    Sales and book value multiples are 5.4x and 8.1x. Its year-end P/E ranged from 12.5x to 17.9x from 2016 to 2025.

    P/E Ratio18.6x
    Forward P/E17.8x
    P/S Ratio5.4x
    Forward P/S5.2x
    P/B Ratio8.1x
    P/FCF Ratio20.4x
    P/OCF Ratio17.5x
    PEG Ratio2.4

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 15.6x EBITDA and 23.0x free cash flow.

    EV / Earnings33.9x
    EV / Sales6.0x
    EV / EBITDA15.6x
    EV / EBIT23.9x
    EV / FCF23.0x

    Price Statistics

    The stock is up 24.97% over 52 weeks and trades 6.41% above its 50-day average.

    Beta (1Y)0.35
    52-Week Change+24.97%
    1-Month Change+5.97%
    3-Month Change-0.72%
    6-Month Change+5.80%
    5-Year Change+94.28%
    10-Year Change+126.40%
    Total Return (1Y)+28.72%
    Total Return (3Y CAGR)+21.72%
    Total Return (5Y CAGR)+17.83%
    Return vs SPY (1Y)+16.58%
    Max Drawdown (1Y)-16.17%
    Max Drawdown (3Y)-19.95%
    Sharpe Ratio (1Y)0.91
    Correlation with SPY (1Y)0.18
    50-Day Average$149.57
    200-Day Average$152.06
    52-Week Range$119.60 to $165.96
    RSI (14 Days)55.1
    Average Volume (20 Days)2.18M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.88x current liabilities, and total debt is 1.25x shareholder equity.

    Current Ratio0.88x
    Quick Ratio0.70x
    Debt / Equity1.25x
    Debt / EBITDA2.13x
    Debt / FCF3.12x
    Interest Coverage9.02x

    Returns and Efficiency

    Return on invested capital is 13.48% over the last 12 months, against a 5-year average of 15.10%.

    Return on Equity (ROE)26.95%
    Return on Assets (ROA)8.56%
    Return on Invested Capital (ROIC)13.48%
    Return on Capital Employed (ROCE)16.81%
    ROE (5Y Average)27.29%
    ROA (5Y Average)12.66%
    ROIC (5Y Average)15.10%
    Asset Turnover0.50x
    Inventory Turnover2.32x
    Receivables Turnover5.68x
    Cash Conversion Cycle113 days

    Taxes

    Income tax took 20.80% of pretax income over the last 12 months.

    Income Tax (TTM)$2.63B
    Effective Tax Rate20.80%

    Scores

    NVS has an Altman Z-Score of 3.60, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score3.60
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue was $56.31B over the last 12 months.

    Revenue$56.31B
    Gross Profit$42.02B
    Operating Income$14.33B
    Pretax Income$12.65B
    Net Income$10.03B
    EBITDA$21.78B
    EBIT$14.22B
    Reported EPS (TTM)$8.55

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 31.78% of the $117.15B in total assets.

    Cash and Equivalents$8.87B
    Total Debt$46.35B
    Net Debt$37.48B
    Working Capital-$3.78B
    Shareholder Equity$37.23B
    Tangible Book Value-$29.77B
    Total Assets$117.15B
    Total Liabilities$79.58B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.48B of capital spending, operating cash flow left $14.84B of free cash flow.

    Operating Cash Flow$17.32B
    Capital Expenditures$2.48B
    Free Cash Flow$14.84B
    FCF Per Share$7.86
    Depreciation and Amortization$7.56B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 25.46%, against a 5-year average of 24.27%.

    Gross Margin74.62%
    Operating Margin25.46%
    Pretax Margin22.46%
    Net Margin17.82%
    EBITDA Margin38.69%
    EBIT Margin25.26%
    FCF Margin26.36%
    Gross Margin (5Y Average)74.19%
    Operating Margin (5Y Average)24.27%
    Net Margin (5Y Average)30.04%

    Growth

    Revenue grew 9.25% a year over 3 years, and EPS 13.63% a year.

    Revenue Growth (3Y CAGR)+9.25%
    Revenue Growth (5Y CAGR)+2.58%
    EPS Growth (3Y CAGR)+13.63%
    EPS Growth (5Y CAGR)+9.21%
    FCF Growth (3Y CAGR)+15.02%
    FCF Growth (5Y CAGR)+9.72%
    Operating Income Growth (3Y CAGR)+30.46%

    Revenue and profit by year

    Dividends and Yields

    NVS pays out 52.50% of earnings as dividends.

    Dividend Per Share (Annual)$4.77
    Dividend Yield3.00%
    Payment ScheduleAnnual
    Dividend Growth (3Y CAGR)+6.30%
    Dividend Growth (5Y CAGR)+5.28%
    Payout Ratio52.50%
    Earnings Yield5.38%
    FCF Yield4.89%
    Shareholder Yield3.00%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on May 11, 2000.

    Last Split DateMay 11, 2000
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 9 similar companies, NVS has the 7th highest P/E.

    P/E Ratio18.6x vs 22.2x median
    P/S Ratio5.4x vs 4.9x median
    ROIC13.48% vs 13.95% median
    Dividend Yield3.00% vs 2.37% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 4.48% and EPS growth at 7.56% a year over the next 5 fiscal years.

    Revenue Growth Forecast (5Y CAGR)+4.48%
    EPS Growth Forecast (5Y CAGR)+7.56%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NVS

    What is NVS's market cap?

    Novartis AG ADR has a market cap of $303.12B. Its enterprise value, which adds debt and subtracts cash, is $340.60B.

    What is NVS's P/E ratio?

    Novartis AG ADR has a trailing P/E ratio of 18.6x and a forward P/E of 17.8x.

    How many shares of NVS are outstanding?

    Novartis AG ADR has 1.91B shares outstanding. The count is down 1.80% from a year earlier.

    Does NVS pay a dividend?

    Yes. Novartis AG ADR pays $4.77 a share a year, a dividend yield of 3.00%.

    How much debt does NVS have?

    Novartis AG ADR has $46.35B of total debt and $8.87B of cash and equivalents, a net debt position of $37.48B.